Dr. Thalhammer-Reyero joined the OTT in 2001. Prior to joining NIH, she was the founder and president of a start-up company, where she developed and patented inventions in the area of computational biology. In earlier years, Dr. Thalhammer-Reyero held various faculty and academic research positions in the areas of immunology, cell biology, cancer biology and biochemistry at Northeastern University, the University of Heidelberg in Germany, Yale University and the University of Vienna in Austria. Dr. Thalhammer-Reyero has a number of publications in peer-reviewed scientific journals and made numerous public presentations related to scientific, business and technology transfer matters. Prior to OTT, she developed and presented business plans to venture capital firms and negotiated various joint-venture and licensing agreements with pharmaceutical, biotech and software companies. She received an M.B.A. in International Business and Finance from the F.W. Olin Graduate School of Business, a Ph.D. in Biochemistry from the University of Vienna in Austria, and Sc.D., M.S. and B.S. degrees in Biology from the Universidad Complutense in Madrid, Spain.